This federal contract award, valued at $2,524.65, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of Nplate 125 MCG vials, a specialized pharmaceutical product, with a performance period ending on January 14, 2025.
DMS Pharmaceutical Group Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.
The contract award does not have a set-aside designation, allowing DMS Pharmaceutical Group Inc. to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group Inc. provides a diverse array of pharmaceutical products and medical supplies to the Department of Defense (DoD) and other federal government agencies.
Generated 3/21/25, 9:58 AM